Payne Ruhlman
About Payne Ruhlman
Payne Ruhlman is an Enterprise Account Executive at o9 Solutions, Inc., where he has worked since 2024. He has a diverse background in consulting and analytics, having held various roles at KPMG US and other organizations, and he possesses extensive experience in supply chain technology transformation and ESG consulting.
Current Role at o9 Solutions
Payne Ruhlman currently serves as an Enterprise Account Executive at o9 Solutions, Inc., a position he has held since 2024. In this role, he works remotely and focuses on managing enterprise-level accounts, leveraging his extensive background in consulting and analytics to drive client success.
Previous Experience at o9 Solutions
Prior to his current role, Ruhlman worked as a Solution Engineer at o9 Solutions, Inc. from 2022 to 2023. During this year-long tenure, he contributed to the development and implementation of solutions tailored to client needs, enhancing operational efficiency and strategic outcomes.
Career Background at KPMG US
Ruhlman's career includes significant experience at KPMG US, where he held multiple roles. He served as a Senior Associate in Strategy from 2020 to 2022 and as an Associate in Supply Chain & Operations Consulting from 2018 to 2020. His work involved consulting for various clients, focusing on strategy and operational improvements.
Education and Academic Achievements
Payne Ruhlman studied at Barrett, The Honors College, where he earned a Bachelor of Science degree from the W. P. Carey School of Business. His academic focus included Business Data Analytics, Finance, and Supply Chain Management, providing a strong foundation for his career in consulting and technology.
Professional Skills and Expertise
Ruhlman has developed expertise in various areas, including ESG consulting, performance improvement, and supply chain technology transformation. He has worked with Fortune 500 clients globally, gaining experience in pre-transaction due diligence and post-transaction planning. His ability to operationalize complex projects has been demonstrated through significant initiatives, including a spin-off for a Global 200 pharmaceutical corporation.